A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam

[1]  R. Coutinho,et al.  The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. , 1992, American journal of epidemiology.

[2]  T. Manolio,et al.  Hostility and health behaviors in young adults: the CARDIA Study. Coronary Artery Risk Development in Young Adults Study. , 1992, American journal of epidemiology.

[3]  G. Dusheiko,et al.  Hepatitis B virus and hepatitis delta virus. , 1992, Molecular and cell biology of human diseases series.

[4]  R. Johnson,et al.  Evidence for the effects of HIV antibody counseling and testing on risk behaviors. , 1991, JAMA.

[5]  T. Holzer,et al.  Low prevalence of sexual transmission of hepatitis C virus in sex partners of seropositive intravenous drug users. , 1991, The Journal of infectious diseases.

[6]  D. Katzenstein,et al.  Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. , 1991, The Journal of infectious diseases.

[7]  T. Bell,et al.  The incidence of HBV infection and syringe exchange programs. , 1991, JAMA.

[8]  C. Hooykaas,et al.  Prevalence of hepatitis C virus infections among heterosexuals with multiple partners , 1991, Journal of medical virology.

[9]  J. Parry,et al.  Prevalence of HIV, hepatitis B and associated risk behaviours in clients of a needle‐exchange in central London , 1991, AIDS.

[10]  D. Katzenstein,et al.  Detection and Qualification of Human Immunodeficiency Virus RNA in Patient Serum by Use of the Polymerase Chain Reaction , 1991 .

[11]  P. Marcellin,et al.  Second generation (RIBA) test in diagnosis of chronic hepatitis C , 1991, The Lancet.

[12]  S. McCurdy,et al.  Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus , 1991, Journal of medical virology.

[13]  F. Taylor.  Decline in hepatitis B cases. , 1991, American journal of public health.

[14]  R. Coutinho,et al.  The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands. , 1991, American journal of public health.

[15]  D. Katzenstein,et al.  Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. , 1991, The Journal of infectious diseases.

[16]  S. Blower.  Behaviour change and stabilization of seroprevalence levels in communities of injecting drug users: correlation or causation? , 1991, Journal of acquired immune deficiency syndromes.

[17]  S. Yerly,et al.  Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. , 1990, AIDS.

[18]  B. Clotet,et al.  Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. , 1990, BMJ.

[19]  H. Margolis,et al.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. , 1990, JAMA.

[20]  A. Saracco,et al.  Incidence and Risk Factors of HIV Infection: A Prospective Study of Seronegative Drug Users from Milan and Northern Italy, 1987–1989 , 1990, Epidemiology.

[21]  J. Goudsmit,et al.  Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. , 1990, The Journal of infectious diseases.

[22]  N. Alexander,et al.  Sexual transmission of human immunodeficiency virus: virus entry into the male and female genital tract. World Health Organization, Global Programme on Acquired Immune Deficiency Syndrome. , 1990, Fertility and sterility.

[23]  M. Stazi,et al.  Incidence of acute hepatitis B in injecting drug users as an indicator of continuing HIV transmission--international implications. , 1990, AIDS.

[24]  H. Reesink,et al.  Infectivity of blood seropositive for hepatitis C virus antibodies , 1990, The Lancet.

[25]  A. Collier,et al.  Plasma viremia in human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[26]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[27]  R A Coutinho,et al.  Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. , 1989, American journal of public health.

[28]  P. Mortimer,et al.  HEPATITIS C VIRUS ANTIBODY , 1989, The Lancet.

[29]  J. Ward,et al.  DURATION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION BEFORE DETECTION OF ANTIBODY , 1989, The Lancet.

[30]  H. Margolis,et al.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. , 1989, JAMA.

[31]  M. Buti,et al.  HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN , 1989, The Lancet.

[32]  J. Eberle,et al.  ANTIBODIES TO HEPATITIS C VIRUS , 1989, The Lancet.

[33]  J. van der Pligt,et al.  Heterosexuals at risk for HIV: differences between private and commercial partners in sexual behaviour and condom use. , 1989, AIDS.

[34]  P. Simmonds,et al.  HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort , 1988, British medical journal.

[35]  J. Goudsmit,et al.  Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. , 1988, AIDS.

[36]  J. Curran,et al.  Sexual transmission of human immunodeficiency virus. , 1986, JAMA.

[37]  R. Coutinho,et al.  Preventing AIDS in drug addicts in Amsterdam [letter] , 1986 .

[38]  Peters Ll.  NOMENCLATURE AND CLASSIFICATION OF THE DISORDERS DUE TO HEAT. , 1964 .